So far, major targets in MM include the B-cell maturation antigen (BCMA), G protein-coupled receptor class C group 5 member D (GPRC5D), and Fc receptor-like 5 (FcRH5) (Table 1 for more details). This evidence concerns the gene FCRL5 and Miyoshi myopathy.